FDA — authorised 12 June 1970
- Application: NDA050219
- Marketing authorisation holder: LILLY
- Local brand name: KAFOCIN
- Indication: CAPSULE — ORAL
- Status: approved
🇺🇸 Kafocin in United States
FDA authorised Kafocin on 12 June 1970
Marketing authorisations
FDA
- Status: approved
Kafocin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Kafocin approved in United States?
Yes. FDA authorised it on 12 June 1970; FDA has authorised it.
Who is the marketing authorisation holder for Kafocin in United States?
LILLY holds the US marketing authorisation.